TACCONELLI, Stefania
TACCONELLI, Stefania
DIPARTIMENTO DI NEUROSCIENZE, IMAGING E SCIENZE CLINICHE
A sulfonimide derivative of bezafibrate as a dual inhibitor of cyclooxygenase-2 and PPARα
2024-01-01 Ammazzalorso, Alessandra; Tacconelli, Stefania; Contursi, Annalisa; Hofling, Ulrika; Cerchia, Carmen; Di Berardino, Sara; De Michele, Alessandra; Amoroso, Rosa; Lavecchia, Antonio; Patrignani, Paola
Altered release of cytochrome p450 metabolites of arachidonic acid in renovascular disease.
2008-01-01 Minuz, P; Jiang, H; Fava, C; Turolo, L; Tacconelli, Stefania; Ricci, M; Patrignani, Paola; Morganti, A; Lechi, A; Mcgiff, Jc
Antiplatelet Agents Affecting GPCR Signaling Implicated in Tumor Metastasis
2022-01-01 Rovati, Gianenrico; Contursi, Annalisa; Bruno, Annalisa; Tacconelli, Stefania; Ballerini, Patrizia; Patrignani, Paola
Antithrombotic Agents and Cancer
2018-01-01 Bruno, A; Dovizio, M; Tacconelli, S; Contursi, A; Ballerini, P; Patrignani, P.
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors
2007-01-01 Renda, Giulia; Zurro, M.; Santarelli, F.; Sacchetta, D.; Tacconelli, Stefania; Zimarino, M.; Patrignani, P.; Romano, Mario; De Caterina, R.
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors
2007-01-01 Renda, Giulia; Zurro, M.; Santarelli, F.; Sacchetta, D.; Tacconelli, Stefania; Zimarino, M.; Patrignani, P.; Romano, Mario; De Caterina, R.
Biology and pharmacology of platelet-type 12-lipoxygenase in platelets, cancer cells, and their crosstalk
2022-01-01 Contursi, Annalisa; Tacconelli, Stefania; Hofling, Ulrika; Bruno, Annalisa; Dovizio, Melania; Ballerini, Patrizia; Patrignani, Paola
Biomarkers of Response to Low-Dose Aspirin in Familial Adenomatous Polyposis Patients
2023-01-01 Lanas, A.; Tacconelli, S.; Contursi, A.; Piazuelo, E.; Bruno, A.; Ronci, M.; Marcone, S.; Dovizio, M.; Sopena, F.; Falcone, L.; Milillo, C.; Mucci, M.; Ballerini, P.; Patrignani, P.
Cardiovascular effects of valdecoxib: transducing human pharmacology results into clinical read-outs.
2008-01-01 Capone, Marta Luciana; Tacconelli, Stefania; Nulll, nullDi Francesco; Petrelli, M; Patrignani, Paola
Celecoxib, ibuprofen and the antiplatelet effect of aspirin in patients with osteoarthritis and chronic stable angina
2006-01-01 Renda, Giulia; Santarelli, F.; Zurro, M.; Sacchetta, D.; Tacconelli, Stefania; Capone, M.; Zimarino, M.; Patrignani, P.; De Caterina, R.
Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease
2006-01-01 Renda, Giulia; Tacconelli, Stefania; Capone, Marta Luciana; Sacchetta, Daniele; Santarelli, Francesco; Sciulli, Maria Gina; Zimarino, M; Grana, Marilena; D'Amelio, Elisabetta; Zurro, Maria; Price, T. S; Patrono, C; DE CATERINA, Raffaele; Patrignani, Paola
Characterization of cyclooxygenase-2 acetylation and prostanoid inhibition by aspirin in cellular systems
2020-01-01 Tacconelli, S; Contursi, A; Falcone, L; Mucci, M; D'Agostino, I; Fullone, R; Sacco, A; Zucchelli, M; Bruno, A; Ballerini, P; Dovizio, M; Patrignani, P.
Characterization of the acetylation of cyclooxygenase-isozymes and targeted lipidomics of eicosanoids in serum and colon cancer cells by the new aspirin formulation IP1867B versus aspirin in vitro
2022-01-01 Hofling, Ulrika; Tacconelli, Stefania; Contursi, Annalisa; Bruno, Annalisa; Mucci, Matteo; Ballerini, Patrizia; Cohen, Simon; Patrignani, Paola
Clinical pharmacology of cyclooxygenase inhibition and pharmacodynamic interaction with aspirin by floctafenine in Thai healthy subjects.
2013-01-01 Maenthaisong, R; Tacconelli, Stefania; Sritara, P; DEL BOCCIO, Piero; Di Francesco, L; Sacchetta, Paolo; Archararit, N; Aryurachai, K; Patrignani, Paola; Suthisisang, C.
CLINICAL PHARMACOLOGY OF CYCLOOXYGENASE INHIBITION BY NAPROXEN AND LOW-DOSE ASPIRIN.
2004-01-01 Patrignani, Paola; Tacconelli, Stefania; Patrono, C; Capone, Ml
Clinical pharmacology of etoricoxib.
2005-01-01 Capone, Ml; Tacconelli, Stefania; Patrignani, Paola
Clinical pharmacology of etoricoxib: a novel selective COX2 inhibitor.
2003-01-01 Patrignani, Paola; Capone, Marta Luciana; Tacconelli, Stefania
Clinical pharmacology of novel selective COX-2 inhibitors.
2004-01-01 Tacconelli, Stefania; Capone, Ml; Patrignani, Paola
CLINICAL PHARMACOLOGY OF PLATELET COX INHIBITION BY NAPROXEN AND LOW-DOSE ASPIRIN.
2003-01-01 Capone, Ml; Tacconelli, Stefania; Patrono, C; Patrignani, Paola
Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects.
2004-01-01 Capone, Ml; Tacconelli, Stefania; Sciulli, Mg; Grana, M; Ricciotti, E; Minuz, P; Di Gregorio, P; Merciaro, G; Patrono, C; Patrignani, Paola
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A sulfonimide derivative of bezafibrate as a dual inhibitor of cyclooxygenase-2 and PPARα | 2024 | Ammazzalorso, Alessandra; Tacconelli, Stefania; Contursi, Annalisa; Hofling, Ulrika; Cerchia, Carmen; Di Berardino, Sara; De Michele, Alessandra; Amoroso, Rosa; Lavecchia, Antonio; Patrignani, Paola | |
| Altered release of cytochrome p450 metabolites of arachidonic acid in renovascular disease. | 2008 | Minuz, P; Jiang, H; Fava, C; Turolo, L; Tacconelli, Stefania; Ricci, M; Patrignani, Paola; Morganti, A; Lechi, A; Mcgiff, Jc | |
| Antiplatelet Agents Affecting GPCR Signaling Implicated in Tumor Metastasis | 2022 | Rovati, Gianenrico; Contursi, Annalisa; Bruno, Annalisa; Tacconelli, Stefania; Ballerini, Patrizia; Patrignani, Paola | |
| Antithrombotic Agents and Cancer | 2018 | Bruno, A; Dovizio, M; Tacconelli, S; Contursi, A; Ballerini, P; Patrignani, P. | |
| Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors | 2007 | Renda, Giulia; Zurro, M.; Santarelli, F.; Sacchetta, D.; Tacconelli, Stefania; Zimarino, M.; Patrignani, P.; Romano, Mario; De Caterina, R. | |
| Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors | 2007 | Renda, Giulia; Zurro, M.; Santarelli, F.; Sacchetta, D.; Tacconelli, Stefania; Zimarino, M.; Patrignani, P.; Romano, Mario; De Caterina, R. | |
| Biology and pharmacology of platelet-type 12-lipoxygenase in platelets, cancer cells, and their crosstalk | 2022 | Contursi, Annalisa; Tacconelli, Stefania; Hofling, Ulrika; Bruno, Annalisa; Dovizio, Melania; Ballerini, Patrizia; Patrignani, Paola | |
| Biomarkers of Response to Low-Dose Aspirin in Familial Adenomatous Polyposis Patients | 2023 | Lanas, A.; Tacconelli, S.; Contursi, A.; Piazuelo, E.; Bruno, A.; Ronci, M.; Marcone, S.; Dovizio, M.; Sopena, F.; Falcone, L.; Milillo, C.; Mucci, M.; Ballerini, P.; Patrignani, P. | |
| Cardiovascular effects of valdecoxib: transducing human pharmacology results into clinical read-outs. | 2008 | Capone, Marta Luciana; Tacconelli, Stefania; Nulll, nullDi Francesco; Petrelli, M; Patrignani, Paola | |
| Celecoxib, ibuprofen and the antiplatelet effect of aspirin in patients with osteoarthritis and chronic stable angina | 2006 | Renda, Giulia; Santarelli, F.; Zurro, M.; Sacchetta, D.; Tacconelli, Stefania; Capone, M.; Zimarino, M.; Patrignani, P.; De Caterina, R. | |
| Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease | 2006 | Renda, Giulia; Tacconelli, Stefania; Capone, Marta Luciana; Sacchetta, Daniele; Santarelli, Francesco; Sciulli, Maria Gina; Zimarino, M; Grana, Marilena; D'Amelio, Elisabetta; Zurro, Maria; Price, T. S; Patrono, C; DE CATERINA, Raffaele; Patrignani, Paola | |
| Characterization of cyclooxygenase-2 acetylation and prostanoid inhibition by aspirin in cellular systems | 2020 | Tacconelli, S; Contursi, A; Falcone, L; Mucci, M; D'Agostino, I; Fullone, R; Sacco, A; Zucchelli, M; Bruno, A; Ballerini, P; Dovizio, M; Patrignani, P. | |
| Characterization of the acetylation of cyclooxygenase-isozymes and targeted lipidomics of eicosanoids in serum and colon cancer cells by the new aspirin formulation IP1867B versus aspirin in vitro | 2022 | Hofling, Ulrika; Tacconelli, Stefania; Contursi, Annalisa; Bruno, Annalisa; Mucci, Matteo; Ballerini, Patrizia; Cohen, Simon; Patrignani, Paola | |
| Clinical pharmacology of cyclooxygenase inhibition and pharmacodynamic interaction with aspirin by floctafenine in Thai healthy subjects. | 2013 | Maenthaisong, R; Tacconelli, Stefania; Sritara, P; DEL BOCCIO, Piero; Di Francesco, L; Sacchetta, Paolo; Archararit, N; Aryurachai, K; Patrignani, Paola; Suthisisang, C. | |
| CLINICAL PHARMACOLOGY OF CYCLOOXYGENASE INHIBITION BY NAPROXEN AND LOW-DOSE ASPIRIN. | 2004 | Patrignani, Paola; Tacconelli, Stefania; Patrono, C; Capone, Ml | |
| Clinical pharmacology of etoricoxib. | 2005 | Capone, Ml; Tacconelli, Stefania; Patrignani, Paola | |
| Clinical pharmacology of etoricoxib: a novel selective COX2 inhibitor. | 2003 | Patrignani, Paola; Capone, Marta Luciana; Tacconelli, Stefania | |
| Clinical pharmacology of novel selective COX-2 inhibitors. | 2004 | Tacconelli, Stefania; Capone, Ml; Patrignani, Paola | |
| CLINICAL PHARMACOLOGY OF PLATELET COX INHIBITION BY NAPROXEN AND LOW-DOSE ASPIRIN. | 2003 | Capone, Ml; Tacconelli, Stefania; Patrono, C; Patrignani, Paola | |
| Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects. | 2004 | Capone, Ml; Tacconelli, Stefania; Sciulli, Mg; Grana, M; Ricciotti, E; Minuz, P; Di Gregorio, P; Merciaro, G; Patrono, C; Patrignani, Paola |